-
The new data suggest doctors can tell patients if they survive the surgery, they will live longer down the road, said Michael Crawford, clinical cardiology chief at University of California at San Francisco, who wasn't involved in the study.
WSJ: Heart Bypass Surgery May Offer Lower Death Risk Than Angioplasty
-
It will keep the people who run cardiology clinical trials quite busy.
FORBES: Big Pharma's Comeback?
-
The statement said the merger might reduce the hospitals' incentives to improve the quality of specialist services, which include rheumatology, rehabilitation, general medicine, general surgery, geriatric medicine, dermatology, clinical haematology, oral and maxillofacial surgery, cardiology and palliative medicine.
BBC: Hospitals merger referred to Competition Commission
-
Cardiology is famous for producing more evidence about our clinical strategies than any other medical field.
FORBES: Practicing Medicine Against the Evidence: The Case of Implantable Defibrillators
-
In a startling break with tradition, the American College of Cardiology and the Society of Thoracic Surgeons will manage and run their own clinical trials testing expanded uses for transcatheter aortic valve replacement (TAVR).
FORBES: Two Medical Societies Break New Ground To Test Medical Device
-
Clinical trials "don't get any weightier, " said Steven Nissen, chairman of cardiology at the Cleveland Clinic and president of the ACC.
FORBES: Magazine Article
-
The lorcaserin Advisory Committee included representation from the fields of Endocrinology, Cardiology, Pharmacology, Health Policy, Epidemiology, Biostatistics, Internal Medicine, and Clinical Research.
FORBES: FDA Responds To Outraged Arena Investors
-
In its letter, the FDA noted that the lorcaserin panel contained experts in endocrinology, cardiology, pharmacology, health policy, epidemiology, biostatistics, internal medicine, and clinical research.
FORBES: FDA Responds To Outraged Arena Investors
-
Moliterno, chief of cardiology at the University of Kentucky, who conducted Schering's 1, 000-patient clinical trial.
FORBES: Magazine Article